The Efficacy and Safety of Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia. Single-Arm Phase II Study. Analysis of Complement Activation Pathways.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 14 May 2009 New trial record